Aquire Wealth Advisors’s Dentsply Sirona XRAY Stock Holding History

Aquire Wealth Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3	Closed	–	–	264
2021 Q4	$0	Buy	+3	New	+$165	﹤0.01%	272

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Aquire Wealth Advisors's XRAY Position: Q1 2022 in Review

Aquire Wealth Advisors sold out of Dentsply Sirona (XRAY) in Q1 2022, closing a stake of 3 shares.

Aquire Wealth Advisors first reported a position in XRAY in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 536 funds tracked by Wall St. Rank hold XRAY as of Q1 2022.

Aquire Wealth Advisors reported no remaining Dentsply Sirona position as of Q1 2022 after selling out during the quarter.
Aquire Wealth Advisors sold 3 Dentsply Sirona shares in Q1 2022.
Aquire Wealth Advisors first reported a position in Dentsply Sirona in Q4 2021 and held it in 1 quarter.
Aquire Wealth Advisors's Dentsply Sirona position peaked at $0 in Q4 2021.
536 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2022.

Based on Aquire Wealth Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.